About
Team
Management Team
Supervisory Board
Scientific Advisory Board
Erasmus MC Partner
Science
How TCR-T cell therapy works
Next-generation T cell therapy
Pipeline
Investors
News
Contact
Our latest news
Pan Cancer T BV extends partnership with NecstGen BV by initiating retroviral vector development
Pan Cancer T secures eur 4.25 Million in Seed Extension Round to advance next-generation T cell therapies
Erasmus MC together with Pan Cancer T receive KWF-PPS grant to develop next-generation T cell therapy
Pan Cancer T has been awarded the Seal of Excellence from the European Commission
Pan Cancer T has been selected as semi finalist of the EIT Health Catapult venture challenge
Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer
Pan Cancer T is presenting preclinical data at CIMT and SITC 2023
Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board
Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer
Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital
